ABT vs MDT
As of Sep 20, 2026, Abbott Laboratories (ABT) scores 5.3/10 and Medtronic (MDT) 5.7/10 on AlphaStocks' five-model composite, so MDT scores higher. ABT trades 4% below its model fair value; MDT trades 11% below its model fair value.
ABT
ABBOTT LABORATORIES
5.3
Consider Buy
$102.57
MDT
Medtronic plc
5.7
Consider Buy
$92.13
ABT vs MDT: Which is the Better Investment?
ABBOTT LABORATORIES (ABT) scores 5.3/10 while Medtronic plc (MDT) scores 5.7/10 on AlphaStocks' composite model. Medtronic plc has the higher composite rating of Consider Buy. On a P/E basis, Medtronic plc trades at 24.7x, making it the more attractively priced of the two. Medtronic plc trades further below its estimated fair value.
This comparison is algorithmically generated and is not financial advice.
| Metric | ABT | MDT |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 5.3/10 | 5.7/10▲ |
| Rating | Consider Buy | Consider Buy▲ |
| Price | $102.57 | $92.13 |
| P/E Ratio | 27.5 | 24.7▲ |
| ROE | 12.7%▲ | 9.8% |
| Market Cap | $179B | $118B |
| Fair Value | $107.10 | $103.00 |
| Dividend Yield | 2.5% | 3.6%▲ |
| Sector Rank | #85 of 168 | #68 of 168▲ |
| Model Verdicts | ||
| Piotroski | Attractive | Strong▲ |
| Buffett | Strong▲ | Attractive |
| Graham | Neutral | Neutral |
| Lynch | Neutral | Neutral |
| Greenblatt | Attractive | Strong▲ |
Related comparisons
ABT vs MDT: Which Stock Scores Higher?
ABBOTT LABORATORIES (ABT) and Medtronic plc (MDT) are both in the Health Care sector. MDT currently leads with a composite score of 5.7/10 (Consider Buy) compared to ABT's 5.3/10 (Consider Buy).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer